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Purpose: To examine the state of herbal medicines research and development (R&D) outputs in 
universities, research institutes and pharmaceutical manufacturing firms in Nigeria. 
Methods: Questionnaires were administered to core researchers in the above-mentioned research 
organizations using purposive and convenient sampling technique. The questionnaire elicited vital 
information on researcher’s area of specialization, academic qualifications, state of research facilities 
and approach to herbal medicines R&D by the organization. Data were analyzed using appropriate 
statistical tools. 
Results: The study revealed that the researchers were highly qualified individuals who specialized in 
eight distinct areas. Research facilities were in varying degrees of deterioration. Major R&D activities 
were incremental or modification of products/process (58 %), continuous improvement of R&D programs 
(23 %), radical process/product development (20 %), and creative (11 %) and duplicative (7 %) efforts. 
Strategies to enhance herbal medicine R&D were increased funding (36.3 %), training of researchers 
(28.1 %), improvement in R&D infrastructure (18.6 %) and fostering public-private partnership (17 %). 
Conclusion: Herbal medicines R&D is not fully developed in Nigeria due to a myriad of fundamental 
challenges facing the key players. 
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In Nigeria, the major actors in research and 
development (R&D) in herbal medicines are 
private and public-funded research institutes, 
universities and pharmaceutical manufac-
turing firms. Together, these organizations 
not only represent the bedrock of most R&D 
activities, but are also responsible for 
capacity building and training of manpower in 
the sector. However, failure to utilize such 
knowledge outputs may lead to stagnation of 
social and economic progress [1].  
 
R&D activities could be enhanced through 
partnerships. Partnerships exist within the 
health R&D system and these include 
government-industry, research institute-
industry, university-industry and any of these 
combination [2]. Contract research also exist 
between some pharmaceutical firms that 
produce herbal medicines and multinational 
corporations overseas. In any case, it has 
been reported, that industry partnership with 
research institutes is more common than with 
universities [3,4]. Besides, the nature of 
pharmaceutical R&D activities has been 
identified as duplicative, creative, incremental 
or modification of products/process, radical 
product /process – development, aggressive 
and defensive [2]. 
 
Furthermore, it has been established that 
plant preparations undergo value-addition or 
marked improvements in quality, through 
R&D [5]. Presently, most herbal preparations 
not only come in various forms, such as 
chewable and compressed tablets, but also in 
soft gelatin capsules and as creams, 
ointment in collapsible tubes or as 
flavored/coloured syrups [6]. Meanwhile, the 
mode of pharmaceutical R&D employed in 
the production of these new and improved 
herbal medicines from Far East Asian 
countries has been established. However, 
this is not the case with herbal medicine 
pharmaceutical R&D in Nigeria [7].  
 
Current major issue in academic disclosure is 
the claim that most herbal medicinal products 
developed in Nigeria are not supported with 
proven R&D. Consequently, there are many 
who have reservations about these medicinal 
products [8]. This study, therefore, seeks to 
provide answers to the following questions 
namely: What is the nature of the Nigerian 
herbal medicine R&D? What are the 
dominant herbal medicine R&D types? What 
strategies are required to enhance such R&D 






Major actors within the national health 
innovation system environment (NHISE) 
where herbal medicine R&D activities take 
place in Nigeria were covered, namely, 
pharmacognosy departments/drug production 
units of universities, research institutes and 
herbal medicine producers/pharmaceutical 




The sample population consisted of 13 
universities involved in herbal medicine R&D, 
3 research institutes and 50 herbal medicine 
manufacturing pharmaceutical firms/herbal 
medicine producers. Approx. 90 % of the 
pharmaceutical manufacturing firms in 
Nigeria are located in southwestern part of 
the country [10]. In all, the sample size was 
325, made up of 100 respondents each from 
universities and research centres, and 125 




The 13 universities, which consists of 9 
Federal government-owned, 2 state 
government-owned, and 2 privately-owned 
universities, were selected using a purposive 
and convenient sampling technique from the 
list of universities (sample frame) that offer 
courses in pharmacy [11]. The research 
institutes were drawn from two broad 
disciplines, namely, medical and natural 
sciences which reflect their mandates. 
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Random sampling technique was employed 
to select respondents in the research 
institutes and manufacturing pharmaceutical 
subsectors to minimize bias. 
 
Design and administration of 
questionnaire.  
 
Three different sets of questionnaire were 
designed and administered. The 
questionnaire for universities and research 
institutes were administered to the Dean of 
the pharmacy school and/or Chairmen of 
research committee as well as to the, senior 
manager or officer of the institute responsible 
for the management of research activities, or 
any appropriate person identified by the Dean 
of pharmacy school or director of the 
research institutes. The questionnaire was 
also given to core researchers in herbal 
medicine R&D. The questionnaire for 
manufacturing pharmaceutical firms/herbal 
medicine producers was administered to 
senior R&D and production managers who 
also responded to questions in a follow-up 
personal interview session. Each 
questionnaire had two components: 
classification questions and questions on 
core issues .Classification questions assisted 
in classifying the targeted 
institution/organization by age, size or sector 
of operation for the purpose of analysis. The 
questions on core issues were derived from 
the statement of the problem and research 
questions hitherto formulated. The choice of 
any particular type of question was based on 
its appropriateness and power to elicit 
precise response to questions. All research 
instruments and interview schedules were 
pre-tested and subsequently used to make 
necessary modifications and corrections on 
the questionnaire before they were 
administered to respondents. In all, a total of 
240 questionnaires were returned, consisting 
of 74 from universities, 66 from research 
institutes and 100 from pharmaceutical 
manufacturing firms/herbal medicine 
producers.   
 
Data analysis                  
  
Data were collated, coded and variables 
given sequential numbers, and then analyzed 
using Statistical Package for Social Sciences 
(SPSS) ,version 12, software. The results are 
expressed  in percentages . A p-value < 0.05 
was considered as statistically significant for 




Table 1 shows the educational qualification of 
the respondents. The proportion of PhD. 
degree holders among herbal medicine 
researchers was greater in the universities 
(38.8 %) than in research institutes (30.3 %) 
and herbal medicine manufacturing firms (3.0 
%). On the other hand, middle manpower 
(HND, BSc and MSc degree holders) were 
proportionally more in research institutes and 
herbal medicine manufacturing firms than in 
universities. The differences were statistically 
significant at p < 0.05. 
 
Specialties of herbal medicine R&D 
researchers 
 
Close to half (45.8%) of herbal medicine 
researchers (were in the specialty of
Table 1: Qualifications of herbal medicine researchers 
 
Organization  HND BSc MSc  PhD Total 
Universities - 4 (5.4%) 8(10.8%) 62(38.8%) 74(100%) 
Research institutes 4(6.1%) 14(21.2%) 28(42.4%) 20(30.3%) 66 (100%) 
PMHP 11(11.0%) 31(31%) 55(55.0%) 3(3%) 100 (100%) 
Total 15(6.3%) 49(20.42%) 91(37.9%) 85(35.4%) 240 (100%) 
PPMHP = pharmaceutical manufacturing firms/herbal medicines producersHND = Higher National 
Diploma; MSc = Master of Science; BSc = Bachelor of Science; PhD = Doctor of Philosophy 
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pharmacology, while  19.6 % were in 
photochemistry. Microbiology accounted for 
17 %, and formulation/compounding 6.7 %, 
Others were herbarium, conservation/ 
cultivation and environmental studies 
recorded 3.8, 2.9 and 4.2 % of the 
researchers, respectively. 
 
State of research facilities in herbal 
medicine R&D organizations 
  
The study revealed (Table 2) that research 
facilities in herbal medicine pharmaceutical 
manufacturing firms/herbal medicine 
producers were generally in better state than 
those in universities and research institutes. 
R&D facilities in herbal medicine 
pharmaceutical manufacturing firms were 
considered adequate by 88 % of the 
respondents; this was buttressed by 94 % of 
respondents who rated the degree of 
equipment obsolescence in the sector to be < 
40 %. The reverse, however, was the case 
for the state of facilities in universities and 
research institutes where 86 % and 91 % of 
the respondents in universities and research 
institutes, respectively, rated the facilities as 
poor; those who also ategorized the facilities 
as being in varying degrees of deterioration 
was in the range of 60 – 80 %. 
 
Types of herbal medicine R&D activities 
 
The dominant R&D activity types were 
identified amongst the various herbal 
medicine research organizations, namely, 
incremental and modification of 
products/process, and continuous 
improvement of R&D program. However, the 
degree to which these two R&D activities 
were practiced differed from one organization 
to the other (Table 3). Majority of the herbal  
 
Table 2: Respondents assessment of the state of research facilities in herbal medicine R&D organizations  
 
Facilities Universities Research institutes Manufacturing firms 
Level of adequacy 
Very inadequate 31(41.9%) 32(48.5%) 0(0.0%) 
Inadequate 33(44.6%) 28(42.4%) 0(0.0%) 
Fair 10(13.5%) 3(4.55%) 12(12.0%) 
Adequate 0(0.0%) 3(4.55%) 35(35.0%) 
Very adequate 0(0.0%) 0(0.0%) 53(53.1%) 
Degree of  obsolescence (%) 
0 – 20 0(0.0%) 0(0.0%) 53(53%) 
21 – 40 0(0.0%) 10(15.2%) 41(41.0%) 
41 – 60 25(33.8%) 11(25.0%) 6(6.0%) 
61 – 80 41 (44.4%) 45(60.8%) 0(0.0%) 
>80 8(10.8%) 0(0.0%) 0(0.0%) 
Table 3: Type of herbal medicine R&D activities 
                                       
Type of R&D activity Respondents Organization 
  N            % 
Universities Incremental or modification of product/process    45 60.8 
 Continuous improvement of R&D program  11 14.9 
 Radical process/product development 18 24.3 
Research institutes Incremental or modification of process/product  41 62.1 
 Continuous improvement of R&D program 15 22.7 
 Radical process/product development 10 15.2 
Manufacturing firms Incremental or modification of product/process 51 51.0 
 Continuous improvement of R&D program 31 31.0 
 Creative imitation 11 11.0 
 Duplicative imitation 7 7.0 
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medicine researchers in universities (60.8 %), 
research institutions (62.1 %) and 
manufacturing firms (51.0 %) indicated that 
incremental or modification of 
product/process was their dominant R&D 
activity.  
 
Another prominent R&D type was continuous 
improvement of R&D programs. This was 
more pronounced in manufacturing 
firms/herbal medicine producers (31 %), than 
in research institutes (22.7 %) and 
universities (14.9 %). Radical 
process/product development R&D activity 
was practiced only by R&D researchers in 
universities (24.3 %) and research institutes 
(15.2 %).  
 
On oral interview, majority (36.3 %) of the 
herbal medicine R&D researchers in the 
various organizations averred that one major 
strategy for improving R&D process is to 
increase R&D funding. Other researchers 
believed that improved capacity building 
programs for R&D researchers (28.1 %), 
provision of modern research facilities (18.6 
%) and public-private partnership (17.0 %) 
would also enhance herbal medicine R&D 




The preponderance of highly qualified herbal 
medicine researchers in the universities and 
research institutes indicate that these 
organizations are centers of knowledge 
generation. Basically, the main focus in terms 
of job content in these institutes is teaching 
and research. Therefore, concentration of 
highly qualified specialists and therefore 
those skillful in handling advanced research 
facilities would normally be expected to be 
higher in universities and research institutes 
than in manufacturing firms, and this is 
buttressed by the findings of this study. The 
pattern of the quality of researchers across 
the various organizations studied can be 
attributed to the nature of tasks in each of the 
organizations.  
 
 Furthermore, the proportion of researchers in 
areas such as herbarium conservation/ 
cultivation and environmental studies were 
low. This could be one of the reasons why 
only a handful of active full-time trained 
ethnobotanists exist to catalog information on 
medicinal properties of plants [7]. In any 
case, researchers may be active in more than 
one area; though R&D researchers are 
usually specialists in their area of core 
competence. 
 
Our findings on the state of research facilities 
in the organizations corroborate those of  
previous works [12] where it was also 
reported that research facilities in educational 
institutions and public research institutes 
were in a very poor state but those in the 
industries were better. This could be linked to 
the degree of funding in the various research 
organizations. It has been established 
elsewhere that the funding of research 
activities in the universities and public 
research institutes was poor when compared 
to what obtains in private research 
organizations/industries [10].   
 
The present study indicates that R&D 
organizations in Nigeria mainly transform 
products or processes by either modifying or 
improving on existing production knowledge. 
This may be in response to certain unfolding 
activities in the competitive market 
environment such as changes in tastes, 
demand, and presence of other competing 
brands, among others. The ability to modify 
an existing product/process requires in-house 
R&D capability. Radical innovation is 
associated with scientific or engineering 
principles not previously in use. To undertake 
such research, there is a need for strong in-
house R&D capabilities as well as creative 
and innovation-minded scientists. The 
present study shows that creative and 
duplicative research was mainly undertaken 
in manufacturing firms. This may be in 
response to competitive forces in the external 
environment where competition for larger 
market share in the industry is a major driving 
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force, especially as the outputs of these firms 
are product-oriented.  
 
Limitations of the study 
 
This study was limited to R&D outputs in 
herbal medicine. The names of herbal 
medicines  that were derived from such R&D 
processes were not mentioned. This, 
however, is unlikely to significantly affect the 




Pharmaceutical R&D in herbal medicine is 
not fully developed in Nigeria due to the 
myriads of challenges highlighted in this 
study. However, the R&D process can be 
considerably improved if appropriate 
strategies, such as those highlighted by the 
respondents in this study are adopted and 
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